Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ATP5L | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | OGDH | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | HSPA9 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | PACSIN1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CTD-2550O8.5 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | TULP4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TAPT1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ALDH9A1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | SBNO2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | ZBTB43 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |